(via TheNewswire)
A total of 19,081,184 common shares of theCompany(“Shares”) representing 6.31% of the 302,177,103 issued and outstanding Shares were voted in connection with the Meeting. Shareholders approved all items of business before the Meeting, including the election of directors as follows:
Nominee | # Votes For | % Votes For | # Votes Withheld | % Votes Withheld |
John William Arbuthnot III | 16,583,244 | 86.91% | 2,497,940 | 13.09% |
John William Arbuthnot IV | 16,347,101 | 85.67% | 2,734,083 | 14.33% |
16,414,259 | 86.02% | 2,666,925 | 13.98% | |
18,632,519 | 97.65% | 448,665 | 2.35% | |
16,577,410 | 86.88% | 2,503,774 | 13.12% |
Shareholders also voted in favour of the reappointment of
For more information contact:
Investor & Media Contact:
Mobile: 204-898-7722
E-mail: ian.chadsey@delta9.ca
About
quality cannabis products to market. The Company sells cannabis products through its wholesale
and retail sales channels and sells its cannabis grow pods to other businesses. Delta 9’s wholly-owned subsidiary, Delta 9
cannabis and operates a 95,000 square foot production facility in
Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. Delta
9’s shares trade on the
the symbol “DLTNF”. For more information, please visit www.delta9.ca.
Copyright (c) 2024 TheNewswire - All rights reserved.
Copyright (c) 2024 TheNewswire - All rights reserved., source